• Almac Group Completes $7M R&D Center contractpharma
    February 24, 2021
    ​Almac Sciences, a member of the Almac Group, has completed a roughly $7 million investment in a new two-storey center for biocatalysis, flow chemistry technologies and peptide research and development.
PharmaSources Customer Service